An Orally Bioavailable C-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
Anti-Cancer Agents in Medicinal Chemistry - United Arab Emirates
doi 10.2174/1871520611009010028
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2010
Authors
Publisher
Bentham Science Publishers Ltd.